Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market Size, Share & Trends Analysis Report by Treatment (Appetite Stimulants, Corticosteroids), Type (Lung Cancer, Colorectal Cancer), Distribution Channel and Region with Growth Forecasts, 2025-2033" has been added to ResearchAndMarkets.com's offering.
The global cancer cachexia market, valued at USD 2.54 billion in 2024, is projected to expand to USD 3.90 billion by 2033, with a CAGR of 4.86% from 2025 to 2033. This growth is propelled by the rising incidence of cancer, more patients being affected by cachexia, and a heightened awareness of its clinical and economic impacts.
Global Cancer Cachexia Market Report Segmentation
This detailed report provides a forecast of revenue growth at global, regional, and national levels and analyzes the latest industry trends across sub-segments from 2021 to 2033. The market report is segmented based on treatment, type, distribution channel, and region:
Treatment Outlook (Revenue, USD Million, 2021-2033)
- Appetite Stimulants
- Cannabinoid Receptor Agonists
- Corticosteroids
- Anabolic/Androgenic Agents
- Others
Type Outlook (Revenue, USD Million, 2021-2033)
- Pancreatic Cancer
- Gastric (Stomach) Cancer
- Lung Cancer
- Colorectal Cancer
- Others
Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Why should you buy this report?
- Comprehensive Market Analysis: Gain insights on major regions and segments.
- Competitive Landscape: Analyze the market presence of key players.
- Future Trends: Identify key trends and drivers in the marketplace.
- Actionable Recommendations: Leverage insights for strategic business decisions.
This report addresses:
- Market intelligence for informed decision-making
- Forecasts and estimates from 2018 to 2030
- Growth opportunities and trend analysis
- Segment and regional revenue forecasts for assessment
- Competition strategies and market share analysis
- Product innovation for staying ahead
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value (USD) in 2024 | $2.54 Billion |
| Forecasted Market Value (USD) by 2033 | $3.9 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
Companies Featured
The key companies profiled in this Cancer Cachexia market report include:
- AbbVie Inc.
- Endo, Inc.
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Abbott.
- Nestle Health Science
- Baxter.
- Fresenius Kabi AG
- Sandoz Group AG
- Bristol-Myers Squibb Company
For more information about this report visit https://www.researchandmarkets.com/r/vf7ha6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
